BIAF Stock Price | bioAffinity Technologies, Inc. P/E, Revenue, EPS, & Forecasts

bioAffinity Technologies, Inc. • BIAF

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About bioAffinity Technologies, Inc.

Ticker

BIAF

Trading on

NASDAQ

ISIN

US09076W1099

Industry

Diagnostics & Research

Sector

Healthcare

CEO

Maria Zannes J.D.

Headquarters

22211 West Interstate 10, San Antonio, TX, United States, 78257

Employees

Website

bioaffinitytech.com

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.

Metrics

BasicAdvanced

Market cap

$9.2M

P/E ratio

EPS

-$0.73

Dividend Yield

0.00%

Beta

3.47

Forward P/E ratio

EBIDTA

$-8.3M

Ex dividend date

Price & volume

Market cap

$9.2M

Average daily volume

27.7M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

0.98

Price to book

3.53

Earnings

EPS

-$0.73

EPS estimate (current quarter)

-$0.15

EPS estimate (next quarter)

$0.00

EBITDA

$-8.3M

Revenues (TTM)

$9.4M

Revenues per share (TTM)

$0.77

Technicals

Beta

3.47

52-week High

$2.99

52-week Low

$0.24

50-day moving average

$0.53

200-day moving average

$1.27

Short ratio

0.11

Short %

2.07%

Management effectiveness

ROE (TTM)

242.44%

ROA (TTM)

75.95%

Profit margin

96.56%

Gross profit margin

$3.4M

Operating margin

133.47%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.30%

Share stats

Outstanding Shares

18M

Float

14.1M

Insiders %

27.76%

Institutions %

2.93%

Analyst Insights & forecasts

0% Buy

100% Hold

0% Sell

Based on information from 1 analysts.

Average price target

$6.00

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.26

-$0.20

28.35%

Q1 • 24Beat

-$0.19

-$0.17

11.76%

Q2 • 24Beat

-$0.16

-$0.15

6.67%

Q3 • 24Beat

-$0.19

-$0.14

35.71%

Q4 • 24Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$2.4M

$-2M

85.13%

Q3 • 24

$2.2M

$-3M

134.40%

Q4 • 24

6.08%

48.28%

57.87%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$6.6M

$3.4M

52.37%

Q3 • 24

$6.5M

$3.9M

60.05%

Q4 • 24

0.59%

14.01%

14.68%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-1.7M

$-0M

$1.7M

$-1.7M

Q3 • 24

$-1.7M

$-0M

$2M

$-1.7M

Q4 • 24

1.88%

99.99%

21.03%

2.41%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a bioAffinity Technologies, Inc. share?

bioAffinity Technologies, Inc. shares are currently traded for undefined per share.

How many shares does bioAffinity Technologies, Inc. have?

bioAffinity Technologies, Inc. currently has 18M shares.

Does bioAffinity Technologies, Inc. pay dividends?

No, bioAffinity Technologies, Inc. doesn't pay dividends.

What is bioAffinity Technologies, Inc. 52 week high?

bioAffinity Technologies, Inc. 52 week high is $2.99.

What is bioAffinity Technologies, Inc. 52 week low?

bioAffinity Technologies, Inc. 52 week low is $0.24.

What is the 200-day moving average of bioAffinity Technologies, Inc.?

bioAffinity Technologies, Inc. 200-day moving average is $1.27.

Who is bioAffinity Technologies, Inc. CEO?

The CEO of bioAffinity Technologies, Inc. is Maria Zannes J.D..

How many employees bioAffinity Technologies, Inc. has?

bioAffinity Technologies, Inc. has 57 employees.

What is the market cap of bioAffinity Technologies, Inc.?

The market cap of bioAffinity Technologies, Inc. is $9.2M.

What is the P/E of bioAffinity Technologies, Inc.?

The current P/E of bioAffinity Technologies, Inc. is null.

What is the EPS of bioAffinity Technologies, Inc.?

The EPS of bioAffinity Technologies, Inc. is -$0.73.

What is the PEG Ratio of bioAffinity Technologies, Inc.?

The PEG Ratio of bioAffinity Technologies, Inc. is null.

What do analysts say about bioAffinity Technologies, Inc.?

According to the analysts bioAffinity Technologies, Inc. is considered a hold.